Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-08-02

Clinical Trial Update: The Tilburg Vasospasm Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating brain ischemia with intracranial vasospasm (The Tilburg Vasospasm Study) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elisabeth-TweeSteden Ziekenhuis | Conditions: Brain Ischemia, Intracranial Vasospasm | Phase 2, Phase 3 | Status: TERMINATED